737,320LIABILITIES AND STOCKHOLDERS' DEFICITCURRENT LIABILITIESAccounts payable and accrued expenses
105,080Accrued interest11,966Other current liabilities35,000Notes payable, current portion77,585Total Current Liabilities229,631LONG-TERM LIABILITIESNotes payable92,018Convertible notes payable, net147,500Total Long-Term Liabilities239,518TOTAL LIABILITIES469,149STOCKHOLDERS' DEFICITCommon stock; $0.001 par value, 60,000,000 shares authorized; 16,696,235 and 17,152,235 shares issued and outstanding, respectively17,153Additional paid-in capital2,299,428Deficit accumulated during the development stage(2,048,410)Total Stockholders' Deficit268,171TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
737,320 KELYNIAM GLOBAL, INC.Statements of OperationsFor the Three Months EndedMarch 31,2012REVENUES
210,635COSTS OF GOODS SOLD113,006GROSS MARGIN97,629OPERATING EXPENSESDepreciation and amortization33,956Professional fees18,601Commissions, salaries and wages138,268General and administrative expense63,375Total Operating Expenses254,200OPERATING LOSS(156,571)OTHER INCOME (EXPENSE)Interest expense(37,548)Total Other Income (Expense)(37,548)NET LOSS BEFORE INCOME TAXES(194,119)Provision for income taxes-NET LOSS
(194,119)BASIC AND DILUTED LOSS PER SHARE
(0.01)WEIGHTED AVERAGE NUMBEROF SHARES OUTSTANDING17,100,061A proxy has been distributed to shareholders of record March 27th regarding the annual meeting scheduled for May 11th at the company's headquarters. Shareholders are reminded to vote and return proxies no later than 2pm EST on May 9, 2012.
About Kelyniam Global, IncorporatedKelyniam Global (Pinksheets: KLYG), Inc. specializes in the use of CAD/CAM technology to provide patient specific custom implants
|SOURCE Kelyniam Global Inc.|
Copyright©2010 PR Newswire.
All rights reserved